Articles & Studies

Discover the groundbreaking findings from a study evaluating RADPAD® Radiation Protection shields! This research underscores the vital role of Collective Protection Equipment (CPE) in reducing operator exposure and introduces RADPAD® as an innovative addition to enhance safety. Key findings reveal a 76% reduction in radiation dose along the operator's...

RADPAD Radiation Protection shields have been tested in many clinical studies to prove their efficacy in reducing radiation exposure, including the study below. Throughout 36 endovascular aneurysm repair (EVAR) procedures, dose measurements were taken to evaluate the reduction RADPAD shielding provided. Results showed that scatter radiation...

RADPAD® Radiation Protection shields have been studied in over 40 clinical trials to evaluate the efficacy in how well scatter radiation exposure is attenuated during interventional imaging procedures! The study below evaluated RADPAD shielding across 65 consecutive percutaneous coronary intervention (PCI) procedures. Results found that when using RADPAD...

RADPAD® Radiation Protection shields have been tested in many clinical studies to prove their efficacy in reducing radiation exposure. Throughout 36 endovascular aneurysm repair (EVAR) procedures, dose measurements were taken to evaluate the reduction RADPAD shielding provided. Results showed that scatter radiation was significantly lower at...

Here we present an exciting article discussing the first 10-year report of TAVI durability, which indicates a low rate of structural valve deterioration. John Webb (Center for Heart Valve Innovation, St Paul’s Hospital, Vancouver, Canada) told Cardiovascular News: “We now know that these newer transcatheter valves...